CVS Health (CVS) option implied volatility increases, Amazon (AMZN) has agreed to acquire PillPack
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
CVS Health (CVS) PT Lowered to $84 at RBC Capital on Amazon Effect
June 29, 2018 7:10 AM EDTRBC Capital lowered its price target on CVS Health (NYSE: CVS) to $84.00 (from $91.00) while maintaining an Outperform rating to reflect Amazon's entrance into the pharmacy space.
"We acknowledge that Amazon has disrupted industries in the past, but believe that the stickiness of payer/ pharmacy... More
Buy CVS Health (CVS) and Express Scripts (ESRX) on Amazon/PillPack Deal Weakness - Mizuho
June 28, 2018 11:47 AM EDTMizuho analyst Ann Hynes said they would be buyers of CVS Health (NYSE: CVS) and Express Scripts (NASDAQ: ESRX) amid weakness related to Amazon's purchase of PillPack.
Hynes said the bark of the deal is likely worse than the bite, at lease initially. "Obviously from a multiple perspective, this announcement will weigh on valuation. From an earnings and cash flow perspective, that impact is less clear and our initial thoughts is market share gains will be limited, at least in the intermediate-term. We confirmed... More
